Celldex Therapeutics (CLDX) had the highest return in January 1991 by a US stock in the Biotechnology Industry, returning 47.8%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Celldex Therapeutics (CLDX) | January 1991 | 47.83% |
GT Biopharma (GTBP) | January 1991 | 40% |
Abeona Therapeutics (ABEO) | January 1991 | 27.78% |
Heron Therapeuti (HRTX) | January 1991 | 23.53% |
Anixa Biosciences (ANIX) | January 1991 | 21.11% |
Amgen (AMGN) | January 1991 | 18.96% |
ImmuCell (ICCC) | January 1991 | 13.88% |
XOMA (XOMA) | January 1991 | 10.63% |
Vera Therapeutics (VERA) | January 1991 | 7.14% |
Compass Therapeutics (CMPX) | January 1991 | 5.26% |
CEL-SCI (CVM) | January 1991 | 0% |
Lisata Therapeutics (LSTA) | January 1991 | 0% |
